Past failures pave way for promising new Alzheimer's treatments
Since 2002, close to 300 drug candidates to treat Alzheimer's have run into clinical dead ends. But now, having learned from those failures, researchers are testing—and retesting—a batch of the most promising compounds ...
Jun 3, 2015
0
16